Pictet Asset Management (UK)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Pictet Asset Management (UK)'s AZN Position: Q2 2021 in Review
Pictet Asset Management (UK) reduced its AstraZeneca (AZN) stake by 9.1% in Q2 2021, selling an estimated $2.28M and leaving 207,161 shares worth $49.7M. The position accounts for 0.05% of the portfolio, ranked #343.
Pictet Asset Management (UK) first reported a position in AZN in Q2 2016 and has held it in 3 quarters since. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.
- Pictet Asset Management (UK) held 207,161 shares of AstraZeneca worth $49.7M as of Q2 2021.
- Pictet Asset Management (UK) sold 20,754 AstraZeneca shares in Q2 2021, an estimated $2.28M.
- AstraZeneca made up 0.05% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #343 holding.
- Pictet Asset Management (UK) first reported a position in AstraZeneca in Q2 2016 and has held it in 3 quarters since.
- 771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.